Pregnancy outcomes in Australian patients with systemic lupus erythematosus

Abstract

AbstractBackgroundSystemic lupus erythematosus (SLE) affects women, with the onset of disease typically around the childbearing years.AimsThis study examines the frequency and risk factors for adverse pregnancy outcomes (APOs) in an Australian cohort, and any disease flares during pregnancy and post partum.MethodsFemale patients with SLE enrolled in the Australian Lupus Registry and Biobank (ALRB) between January 2007 and June 2019 were studied. Self‐reported pregnancy history, including adverse foetal or maternal outcomes, was collected at the time of enrolment and updated as appropriate. Baseline demographics, clinical parameters, medication exposure and disease activity were collected. Factors associated with APO were examined using univariate and multivariate logistic regression analyses.ResultsPregnancy history was available in 278 patients; 30% were nulliparous. Most pregnancies occurred before the diagnosis of SLE. Patients who had pregnancies after SLE diagnosis had an earlier age of diagnosis, and had fewer pregnancies. The APO rate was 44.3% in the overall cohort, with most presenting as prematurity with or without foetal growth restriction. Women with APO were also diagnosed with SLE at a younger age and had a higher prevalence of anti‐cardiolipin antibodies and hypocomplementemia. Early age of SLE diagnosis was a significant independent risk factor for APO. No increase in disease flare was observed in those who experienced APO during the observation period of ALRB.ConclusionThis study shows a considerable incidence of APO in patients with SLE, emphasising the need for pre‐pregnancy counselling and collaboration between maternal‐foetal medicine specialists and rheumatologists, especially for women diagnosed with SLE at a younger age.